| Year |
Citation |
Score |
| 2015 |
Suzuki M, Chiwaki F, Sawada Y, Ashikawa M, Aoyagi K, Fujita T, Yanagihara K, Komatsu M, Narita M, Suzuki T, Nagase H, Kushima R, Sakamoto H, Fukagawa T, Katai H, et al. Peripheral opioid antagonist enhances the effect of anti-tumor drug by blocking a cell growth-suppressive pathway in vivo. Plos One. 10: e0123407. PMID 25853862 DOI: 10.1371/Journal.Pone.0123407 |
0.355 |
|
| 2014 |
Fitting S, Zou S, El-Hage N, Suzuki M, Paris JJ, Schier CJ, Rodríguez JW, Rodriguez M, Knapp PE, Hauser KF. Opiate addiction therapies and HIV-1 Tat: interactive effects on glial [Ca²⁺]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity. Current Hiv Research. 12: 424-34. PMID 25760046 DOI: 10.2174/1570162X1206150311161147 |
0.581 |
|
| 2013 |
Uezono Y, Terawaki K, Kashiwase Y, Sudo Y, Sawada Y, Miyano K, Suzuki M, Shiraishi S, Higami Y. Sa1725 A Novel Rat Cachexia Model With Possible Ghrelin Resistance Made by Inoculation of a Gastric 85as2 Cancer Cell Line: A Traditional Japanese Medicine Rikkunshito Ameliorates Cachexia Symptoms by Potentiation of Ghrelin Receptor-Mediated Signaling Gastroenterology. 144: S-293. DOI: 10.1016/S0016-5085(13)61038-0 |
0.33 |
|
| 2011 |
Suzuki M, El-Hage N, Zou S, Hahn YK, Sorrell ME, Sturgill JL, Conrad DH, Knapp PE, Hauser KF. Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and death. Molecular Neurodegeneration. 6: 78. PMID 22093090 DOI: 10.1186/1750-1326-6-78 |
0.618 |
|
| 2008 |
Narita M, Suzuki M, Kuzumaki N, Miyatake M, Suzuki T. Implication of activated astrocytes in the development of drug dependence: differences between methamphetamine and morphine. Annals of the New York Academy of Sciences. 1141: 96-104. PMID 18991953 DOI: 10.1196/Annals.1441.032 |
0.313 |
|
| 2008 |
Matsumoto K, Takayama H, Narita M, Nakamura A, Suzuki M, Suzuki T, Murayama T, Wongseripipatana S, Misawa K, Kitajima M, Tashima K, Horie S. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice. Neuropharmacology. 55: 154-65. PMID 18550129 DOI: 10.1016/J.Neuropharm.2008.05.003 |
0.302 |
|
| 2006 |
Narita M, Miyatake M, Suzuki M, Suzuki T. [The implication of protein kinase C in the cell-cell interaction during the development of dependence on morphine]. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica. 127: 32-5. PMID 16508221 DOI: 10.1254/Fpj.127.32 |
0.324 |
|
| 2006 |
Narita M, Kato H, Kasukawa A, Narita M, Suzuki M, Takeuchi T, Suzuki T. Role of Src family kinase in the rewarding effect and hyperlocomotion induced by morphine. Neuroreport. 17: 115-9. PMID 16407755 DOI: 10.1097/01.Wnr.0000198950.92820.C7 |
0.333 |
|
| 2006 |
Suzuki T, Ozaki M, Suzuki M, Yajima Y, Narita M. Proper use of opioid analgesic Inflammation and Regeneration. 26: 96-100. DOI: 10.2492/Inflammregen.26.96 |
0.362 |
|
| 2005 |
Narita M, Suzuki M, Narita M, Niikura K, Nakamura A, Miyatake M, Aoki T, Yajima Y, Suzuki T. Involvement of spinal metabotropic glutamate receptor 5 in the development of tolerance to morphine-induced antinociception. Journal of Neurochemistry. 94: 1297-305. PMID 16000152 DOI: 10.1111/J.1471-4159.2005.03296.X |
0.311 |
|
| 2004 |
Narita M, Suzuki M, Narita M, Yajima Y, Suzuki R, Shioda S, Suzuki T. Neuronal protein kinase C gamma-dependent proliferation and hypertrophy of spinal cord astrocytes following repeated in vivo administration of morphine. The European Journal of Neuroscience. 19: 479-84. PMID 14725643 DOI: 10.1111/J.0953-816X.2003.03119.X |
0.323 |
|
| 2003 |
Narita M, Ohnishi O, Narita M, Aoki T, Suzuki M, Yajima Y, Funahashi H, Shioda S, Suzuki T. Direct evidence for the activation of phospholipase C gamma 1 by in vivo treatment with morphine in the mouse periaqueductal gray matter. Brain Research. 970: 140-8. PMID 12706255 DOI: 10.1016/S0006-8993(03)02301-1 |
0.308 |
|
| Show low-probability matches. |